Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
AJNR. American Journal of Neuroradiology
|
October 30, 2016
White Matter Injury and General Movements in High-Risk Preterm Infants
C Peyton, E Yang, M E Msall, et al.
The Journal of Urology
|
January 14, 2020
Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?
Mounsif Azizi, Ahmet M Aydin, Ali Hajiran, et al.
The Journal of Urology
|
March 17, 2020
Reply by Authors
Mounsif Azizi, Ahmet M Aydin, Ali Hajiran, et al.
Journal of Clinical Microbiology
|
October 4, 2000
Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae
D H Martin, C Cammarata, B Van Der Pol, et al.
Clinical Genitourinary Cancer
|
October 16, 2018
Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature
Mounsif Azizi, Dominic H Tang, Daniel Verduzco, et al.
Clinical Genitourinary Cancer
|
June 4, 2018
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience
Charles C Peyton, Mounsif Azizi, Juan Chipollini, et al.
The Journal of Urology
|
October 23, 2020
Reply By Authors
Ali Hajiran, Mounsif Azizi, Ahmet M Aydin, et al.
The Journal of Urology
|
August 14, 2020
Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy
Ali Hajiran, Mounsif Azizi, Ahmet M Aydin, et al.
JAMA Oncology
|
September 5, 2018
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer
Charles C Peyton, Dominic Tang, Richard R Reich, et al.
Urologic Oncology
|
July 10, 2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer
Ahmet Murat Aydin, Salim K Cheriyan, Richard Reich, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
AJNR. American Journal of Neuroradiology
|
October 30, 2016
White Matter Injury and General Movements in High-Risk Preterm Infants
C Peyton, E Yang, M E Msall, et al.
The Journal of Urology
|
January 14, 2020
Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?
Mounsif Azizi, Ahmet M Aydin, Ali Hajiran, et al.
The Journal of Urology
|
March 17, 2020
Reply by Authors
Mounsif Azizi, Ahmet M Aydin, Ali Hajiran, et al.
Journal of Clinical Microbiology
|
October 4, 2000
Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae
D H Martin, C Cammarata, B Van Der Pol, et al.
Clinical Genitourinary Cancer
|
October 16, 2018
Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature
Mounsif Azizi, Dominic H Tang, Daniel Verduzco, et al.
Clinical Genitourinary Cancer
|
June 4, 2018
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience
Charles C Peyton, Mounsif Azizi, Juan Chipollini, et al.
The Journal of Urology
|
October 23, 2020
Reply By Authors
Ali Hajiran, Mounsif Azizi, Ahmet M Aydin, et al.
The Journal of Urology
|
August 14, 2020
Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy
Ali Hajiran, Mounsif Azizi, Ahmet M Aydin, et al.
JAMA Oncology
|
September 5, 2018
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer
Charles C Peyton, Dominic Tang, Richard R Reich, et al.
Urologic Oncology
|
July 10, 2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer
Ahmet Murat Aydin, Salim K Cheriyan, Richard Reich, et al.
Page
of 14